日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Restrictive versus standard hyperhydration during high-dose cyclophosphamide for hematopoietic stem cell transplantation: a retrospective cohort study

造血干细胞移植期间高剂量环磷酰胺治疗中限制性与标准性水化:一项回顾性队列研究

Boosman, R J; Chan, R M; Nur, E; Huls, H J; Crul, M; Heerma van Voss, M R

Evaluation of Aciclovir-Induced Nephrotoxicity in Critically Ill Patients: A Propensity-Matched Cohort Study

评估阿昔洛韦在危重患者中引起的肾毒性:一项倾向性匹配队列研究

Boosman, René J; Bosman, Rob J; van der Voort, Peter H J; Franssen, Eric J F

Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC

奥希替尼血浆谷浓度与晚期EGFR突变型非小细胞肺癌患者脑转移发生的关系

Gulikers, Judith L; Veerman, G D Marijn; Jebbink, Merel; Kruithof, Paul D; Steendam, Christi M J; Boosman, René J; Mathijssen, Ron H J; Tjan-Heijnen, Vivianne C G; Driessen, Johanna H M; Dursun, Safiye; Smit, Egbert F; Dingemans, Anne-Marie C; van Geel, Robin M J M; Croes, Sander; Hendriks, Lizza E L

A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed

比较肾功能生物标志物血清肌酐、脑啡肽原和胱抑素C预测培美曲塞清除率

de Rouw, N; Beunders, R; Hartmann, O; Schulte, J; Boosman, R J; Derijks, H J; Burger, D M; van den Heuvel, M M; Hilbrands, L B; Pickkers, P; Ter Heine, R

Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer

药物转运蛋白 ABCB1 和 ABCG2 的种系变异对非小细胞肺癌患者脑内奥希替尼疗效的影响

G D Marijn Veerman, Rene J Boosman, Merel Jebbink, Esther Oomen-de Hoop, Anthonie J van der Wekken, Idris Bahce, Lizza E L Hendriks, Sander Croes, Christi M J Steendam, Evert de Jonge, Stijn L W Koolen, Neeltje Steeghs, Ron H N van Schaik, Egbert F Smit, Anne-Marie C Dingemans, Alwin D R Huitema, Ro

Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial

基于肾功能的培美曲塞给药方案与标准剂量方案的比较:一项随机对照试验

de Rouw, Nikki; Boosman, René J; Burgers, Jacobus A; Huitema, Alwin D R; Dingemans, Anne-Marie C; Derijks, Hieronymus J; Burger, David M; Piet, Berber; Hendriks, Lizza E L; Biesma, Bonne; Pruis, Melinda A; Dumoulin, Daphne W; Croes, Sander; Mathijssen, Ron H J; van den Heuvel, Michel M; Ter Heine, Rob

The Pharmacoeconomic Benefits of Pemetrexed Dose Individualization in Patients With Lung Cancer

培美曲塞剂量个体化治疗肺癌患者的药物经济学效益

de Rouw, Nikki; de Boer, Merel; Boosman, René J; van den Heuvel, Michel M; Burger, David M; Lieverse, Joris E; Derijks, Hieronymus J; Frederix, Geert W J; Ter Heine, Rob

Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib

利托那韦增强激酶抑制剂暴露:一项开放标签、交叉药代动力学概念验证试验(厄洛替尼)

Boosman, René J; de Gooijer, Cornedine J; Groenland, Stefanie L; Burgers, Jacobus A; Baas, Paul; van der Noort, Vincent; Beijnen, Jos H; Huitema, Alwin D R; Steeghs, Neeltje

Analyzing patient experiences using natural language processing: development and validation of the artificial intelligence patient reported experience measure (AI-PREM)

利用自然语言处理分析患者体验:人工智能患者报告体验测量工具(AI-PREM)的开发与验证

van Buchem, Marieke M; Neve, Olaf M; Kant, Ilse M J; Steyerberg, Ewout W; Boosman, Hileen; Hensen, Erik F

The digital scribe in clinical practice: a scoping review and research agenda

临床实践中的数字记录员:范围界定综述和研究议程

van Buchem, Marieke M; Boosman, Hileen; Bauer, Martijn P; Kant, Ilse M J; Cammel, Simone A; Steyerberg, Ewout W